Direktorat Registrasi ObatValid

OFEV

BPOM Number: DKI1752503502A1
Approved: 21 November 2024
Expiry: 11 October 2027
Form: KAPSUL LUNAK; 120.4 MG

About This Registration

OFEV is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number DKI1752503502A1. Its current registration status is Valid, with the licence valid until 11 October 2027. The product is registered to BOEHRINGER INGELHEIM INDONESIA - INDONESIA. BPOM first approved this registration in October 2022. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 13 November 2025. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: Registrasi Obat
Packaging: DUS, 6 ALUBLISTER @ 10 KAPSUL LUNAK
Department: Direktorat Registrasi Obat
Data Last Updated: 13 November 2025

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

BOEHRINGER INGELHEIM INDONESIA - INDONESIA
-, -, -
owner
View profile →

Manufacturing Sites

BOEHRINGER INGELHEIM INDONESIA - INDONESIA
-, -
primary
View profile →

Ingredients (1)

NINTEDANIB ESILATE

Market Intelligence

Owner Portfolio: BOEHRINGER INGELHEIM INDONESIA - INDONESIA holds 80 BPOM registrations
Manufacturer Scale: BOEHRINGER INGELHEIM INDONESIA - INDONESIA produces 80 registered products
Registration Age: Registered for 3 years, 11 months

FDA Cross-Reference

via openFDA

Generic Name: NINTEDANIB
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: ORAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?